| Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis AK Person, SM Chudgar, BL Norton, BC Tong, JE Stout Journal of medical microbiology 59 (7), 834-838, 2010 | 204 | 2010 |
| Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework E Day, M Hellard, C Treloar, J Bruneau, NK Martin, A Øvrehus, O Dalgard, ... Liver International 39 (1), 20-30, 2019 | 137 | 2019 |
| High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic BL Norton, J Fleming, MA Bachhuber, M Steinman, J DeLuca, ... International journal of drug policy 47, 196-201, 2017 | 135 | 2017 |
| Intensive models of hepatitis C care for people who inject drugs receiving opioid agonist therapy: a randomized controlled trial MJ Akiyama, BL Norton, JH Arnsten, L Agyemang, M Heo, AH Litwin Annals of internal medicine 170 (9), 594-603, 2019 | 120 | 2019 |
| Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs J Grebely, J Bruneau, JV Lazarus, O Dalgard, P Bruggmann, C Treloar, ... International Journal of Drug Policy 47, 51-60, 2017 | 76 | 2017 |
| Geographic information system-based screening for TB, HIV, and syphilis (GIS-THIS): a cross-sectional study ND Goswami, EJ Hecker, C Vickery, MA Ahearn, GM Cox, DP Holland, ... Public Library of Science 7 (10), e46029, 2012 | 69 | 2012 |
| Community-based HCV screening: knowledge and attitudes in a high risk urban population BL Norton, CI Voils, SH Timberlake, EJ Hecker, ND Goswami, ... BMC infectious diseases 14, 1-9, 2014 | 66 | 2014 |
| Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy MJ Akiyama, D Lipsey, M Heo, L Agyemang, BL Norton, J Hidalgo, K Lora, ... Clinical Infectious Diseases 70 (12), 2695-2702, 2020 | 61 | 2020 |
| Barriers to using text message appointment reminders in an HIV clinic BL Norton, AK Person, C Castillo, C Pastrana, M Subramanian, JE Stout Telemedicine and E-health 20 (1), 86-89, 2014 | 56 | 2014 |
| Retention in buprenorphine treatment is associated with improved HCV care outcomes BL Norton, A Beitin, M Glenn, J DeLuca, AH Litwin, CO Cunningham Journal of substance abuse treatment 75, 38-42, 2017 | 45 | 2017 |
| The hepatitis C virus treatment cascade at an urban postincarceration transitions clinic L Hawks, BL Norton, CO Cunningham, AD Fox Journal of viral hepatitis 23 (6), 473-478, 2016 | 38 | 2016 |
| A pilot study to evaluate a novel pre-exposure prophylaxis peer outreach and navigation intervention for women at high risk for HIV infection OJ Blackstock, J Platt, SA Golub, AR Anakaraonye, BL Norton, ... AIDS and Behavior 25, 1411-1422, 2021 | 34 | 2021 |
| Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection BL Norton, L Park, LJ McGrath, RJ Proeschold Bell, AJ Muir, S Naggie AIDS patient care and STDs 26 (9), 541-545, 2012 | 33 | 2012 |
| Treatment of chronic hepatitis C in patients receiving opioid agonist therapy: a review of best practice BL Norton, MJ Akiyama, PJ Zamor, AH Litwin Infectious Disease Clinics 32 (2), 347-370, 2018 | 32 | 2018 |
| Current management options for latent tuberculosis: a review BL Norton, DP Holland Infection and drug resistance, 163-173, 2012 | 32 | 2012 |
| Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial AH Litwin, PJ Lum, LE Taylor, SH Mehta, JI Tsui, J Feinberg, AY Kim, ... The Lancet Gastroenterology & Hepatology 7 (12), 1112-1127, 2022 | 29 | 2022 |
| Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy MJ Akiyama, L Agyemang, JH Arnsten, M Heo, BL Norton, BR Schackman, ... BMC infectious diseases 18, 1-11, 2018 | 29 | 2018 |
| The PREVAIL study: intensive models of HCV care for people who inject drugs AH Litwin, L Agyemang, MJ Akiyama, BL Norton, M Heo, Y Ning, ... J Hepatol 66 (1), S72, 2017 | 26 | 2017 |
| Low-threshold buprenorphine treatment in a syringe services program: program description and outcomes A Jakubowski, BL Norton, BT Hayes, BE Gibson, C Fitzsimmons, LS Stern, ... Journal of addiction medicine, 2022 | 25 | 2022 |
| Low adherence achieves high HCV cure rates among people who inject drugs treated with direct-acting antiviral agents BL Norton, MJ Akiyama, L Agyemang, M Heo, I Pericot-Valverde, ... Open Forum Infectious Diseases 7 (10), ofaa377, 2020 | 25 | 2020 |
